Recurring Meeting of Cleveland Clinic Core Team

Date: September 5, 2017

Time: 2:00 PM EST

Means: In person meeting

Attendees:

  1. Ahmet Erdemir
  2. Tammy Owings
  3. Tyler Schimmoeller
  4. Rici Morrill
  5. Benjamin Landis
  6. Robb Colbrunn
  7. Tara Bonner
  8. Andrew Kihyun Cho (Plastic Surgery Research Fellow)

Agenda:

  1. Discuss immediate action items from past meetings.
  2. Manuscripts update.
  3. In vitro testing progress.
  4. Modeling & simulation progress.

  5. Decide immediate action items for next meeting.
  6. Other.

Immediate Action Items:

Notes:

  1. Discuss immediate action items from past meetings.
    • All action items were related to the recurring agenda items; refer to discussions below.
  2. Manuscript update.
    • Tyler submitted a second draft of instrumented ultrasound manuscript to Ahmet on August 25, 2017. Ahmet has to review it.
    • Rici will soon submit a first draft of in vivo data manuscript to Ahmet.
    • Ben is close to a first draft, but he feels like literature review needs improvement. After his first draft, case studies including simulations should be decided upon.
  3. In vitro testing progress.
    • Design and evaluation of testing protocols using instrumented surgical tools have progressed.
      • Tyler and Tara tested the instrumented surgical tools. Tyler will continue testing with free known weights for verification of load measurements.
      • It was decided to change the origin of the scalpel to the tip of the blade instead of divot.
      • The orientation of skin cutting was discussed. The team may spin off a separate set of experiments to understand the role of Langer lines orientations.
    • Preparations for tissue testing have continued.
      • The adapters for the Mach-1 testing system will arrive soon.
      • Tyler will record tissue testing protocols in a spreadsheet format when found in literature. This is similar to Snehal Chokhandre's approach for Open Knee(s) project to understand the literature.
  4. Modeling & simulation progress.

    • Ben is not currently running test cases until new segmentations are complete. Tammy has completed roughly 3/4 of a leg segmentation from in vitro data.
  5. Decide immediate action items for next meeting.
    • See Immediate Action Items above.
  6. Other.
    • None noted.

RecurringMeetings/2017-09-05 (last edited 2017-09-12 12:25:05 by aerdemir)